Diabetic foot complications

1. GLP1R lowers the risk of diabetic foot complications in humans.

   Humans

   Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization · The international journal of lower extremity wounds · 11 Sep 2026

GLP1R →

1. Liraglutide lowers the risk of diabetic foot complications in humans (PRR 0.30 (95% CI 0.26-0.35)).

   Humans

   Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization · The international journal of lower extremity wounds · 11 Sep 2026

Liraglutide →

1. Dulaglutide lowers the risk of diabetic foot complications in humans (PRR 0.49 (95% CI 0.45-0.54)).

   Humans

   Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization · The international journal of lower extremity wounds · 11 Sep 2026

Dulaglutide →

1. Semaglutide lowers the risk of diabetic foot complications in humans (PRR 0.45 (95% CI 0.39-0.51)).

   Humans

   Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization · The international journal of lower extremity wounds · 11 Sep 2026

Semaglutide →

1. GLP-1 receptor agonists lower the risk of diabetic foot complications in humans (PRR 0.56 (95% CI 0.54-0.59)).

   Humanscompared to other ATC-A10 class drugs

   Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization · The international journal of lower extremity wounds · 11 Sep 2026

GLP-1 receptor agonists →